Vivian Liu
Directeur/Membre du Conseil chez AYTU BIOPHARMA, INC.
Fortune : 23 643 $ au 30/04/2024
Profil
Vivian H.
Liu is the founder of Apricus Biosciences, Inc. She currently holds the position of Independent Director at Aytu Biopharma, Inc. and Partner at OxOnc Development LP.
She also serves as the Head-Corporate Affairs at PREMIA Holdings (Hk) Ltd.
In her former positions, Ms. Liu served as the President, CEO & Lead Independent Director at Innovus Pharmaceuticals, Inc. from 2019 to 2020.
She was also the President & Chief Executive Officer at FasTrack Pharmaceuticals, Inc. in 2011.
Additionally, she held the role of Chief Executive Officer at ThermoGenesis Corp.
and Chief Operating Officer, Secretary & Director at ThermoGenesis Holdings, Inc. from 2016 to 2018.
She was a Managing Director at Oxonc Services Co LLC from 2013 to 2017 and an Advisor at Wyche Securities, Inc.Ms. Liu completed her graduate degree at the University of Southern California and her undergraduate degree at the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AYTU BIOPHARMA, INC.
0,15% | 11/08/2023 | 8 325 ( 0,15% ) | 23 643 $ | 30/04/2024 |
Postes actifs de Vivian Liu
| Sociétés | Poste | Début |
|---|---|---|
| AYTU BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/07/2022 |
OxOnc Development LP
 OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Corporate Officer/Principal | - |
| PREMIA Holdings (Hk) Ltd. | Corporate Officer/Principal | 01/10/2018 |
Anciens postes connus de Vivian Liu
| Sociétés | Poste | Fin |
|---|---|---|
| THERMOGENESIS HOLDINGS, INC. | Directeur/Membre du Conseil | 23/08/2023 |
| INNOVUS PHARMACEUTICALS INC | Directeur Général | 14/02/2020 |
| THERMOGENESIS HOLDINGS, INC. | Directeur des opérations | 16/10/2018 |
Oxonc Services Co LLC
 Oxonc Services Co LLC Pharmaceuticals: MajorHealth Technology Part of OxOnc Development LP, Oxonc Services Co LLC is a private company that develops pharmaceutical products. The company is based in Princeton, NJ. | Directeur Général | 01/03/2017 |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Directeur Général | 15/12/2009 |
Formation de Vivian Liu
| University of Southern California | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| THERMOGENESIS HOLDINGS, INC. | Health Technology |
| AYTU BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
Innovus Pharmaceuticals, Inc.
 Innovus Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. Its products focuses in six main categories, including sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. The company was founded on January 15, 1959 and is headquartered in Englewood, CO. | Health Technology |
Wyche Securities, Inc.
 Wyche Securities, Inc. Investment Banks/BrokersFinance Founded in 1996 by Todd Wyche, Brinson Patrick Securities Corp. is an SEC-registered broker/dealer located in New York City. The firm works exclusively with issuers to raise equity capital with little or no impact to stock price, and with a very high level of service and expertise, through their DOCS (Dynamic Offering of Common Stock) at-the-market financing facility. | Finance |
Oxonc Services Co LLC
Oxonc Services Co LLC Pharmaceuticals: MajorHealth Technology Part of OxOnc Development LP, Oxonc Services Co LLC is a private company that develops pharmaceutical products. The company is based in Princeton, NJ. | Health Technology |
OxOnc Development LP
OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Health Technology |
ThermoGenesis Corp. /California/
 ThermoGenesis Corp. /California/ Medical/Nursing ServicesHealth Services ThermoGenesis Corp. engages in the provision of medical laboratories services. The company is headquartered in Rancho Cordova, CA. | Health Services |
FasTrack Pharmaceuticals, Inc.
 FasTrack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FasTrack Pharmaceuticals, Inc. is a privately-held specialty pharmaceutical company engaged in the development of innovative human therapeutic drugs including drugs to treat liver cancer and autoimmune diseases. Their lead product, PrevOnco, is a H+/K+-ATPase inhibitor, which was granted Orphan Drug Status by the FDA in August 2008. PrevOnco is currently in Phase 3 development as a potential second line therapy for patients with liver cancer. They also have an innovative pipeline of novel products for the Over-the Counter markets including Apeaz and Regia, indicated for pain relief and bleeding of the gums, respectively. | Health Technology |
| PREMIA Holdings (Hk) Ltd. |
